Navigation Links
Asymptomatic HIV babies could use earlier treatment

Identifying and treating HIV-infected newborns is a race against the clock, according to a study from the Stanford University School of Medicine and Lucile Packard Children’s Hospital. Researchers found that HIV-infected infants treated with one or two antiretroviral drugs within two months of birth were less likely to develop AIDS by their third birthday than were infants who were 3 or 4 months old when treatment was initiated. Infants who received a combination of three antiretroviral drugs did even better.

“This is an important finding because there’s been a lot of controversy in the literature as to whether infected but asymptomatic infants should be started on therapy right away,?said the study’s senior author Yvonne Maldonado, MD, a pediatric infectious disease expert at Lucile Packard Children’s Hospital and an associate professor of pediatrics at Stanford’s School of Medicine.

Without any kind of treatment, about 20 to 30 percent of HIV-infected infants will develop AIDS by around 4 months of age. The rest will not have advanced symptoms until they are about 6 years old. The study, published May 11 in the Journal of the American Medical Association, suggests that early treatment might be appropriate for at least some apparently healthy infected infants.

“There is a significant difference in the likelihood of disease progression [with earlier treatment], even though there is only about a month separating the initiation of therapy in the two groups,?Maldonado said. “And none of the children who received triple therapy progressed to AIDS before their third birthday, regardless of the age at which they began therapy.?(Therapy with a combination of three drugs, known as highly active antiretroviral therapy, or HAART, was not available when the study began in 1988.)

Current guidelines for treating HIV-infected infants leave the decision of when to begin treatment to the child’s physician—in part because the long-term effects of ongoi
'"/>

Source:Stanford University


Page: 1 2 3

Related biology news :

1. OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies
2. New brain scan technology could save babies lives
3. New tool tracks brain development in babies
4. Todays babies are fatter babies
5. Research offers new hope for preterm babies
6. Hair samples show babies can be exposed to crystal meth while in the womb
7. Solvent exposure linked to birth defects in babies of male painters
8. Designer babies - what would you do for a healthy baby?
9. Why do cold animals make bigger babies?
10. A revolution in the monitoring of unborn babies
11. Thymus transplants gives hope to babies with fatal immune disease
Post Your Comments:
(Date:5/14/2008)...BOR, Mich.---Researchers have developed what they ...ars for inhibiting a common target used to treat a...new class of AIDS drugs. , Researchers at the Un...op the inhibiting compound, and then confirmed in ...protease, which is an established target for AIDS ...
(Date:5/14/2008)...ities of Oregon white oak were once widespread in ...y, they are in decline. Fire suppression, conifer ...ge have resulted in the loss of as much as 99 perc... some areas of the region. , A new technical rep...or Managing Oak at Tenalquot Prairie, Washington" ...
(Date:5/14/2008)...han 1,400 of the world,s top experts on evolution ...volution 2008," the world,s largest annual gatheri... premier international event for scientists to sha...the University of Minnesota,s Bell Museum of Natur... Sciences and Minnesota Citizens for Science Educa...
(Date:5/14/2008)...DGE, Mass. May 14, 2008 A team composed of Harva...e World Banks Lighting Africa 2008 Development Mar...y 6 to 8, 2008. The innovation, microbial fuel cel...Africa, netted the group a $200,000 prize. , Acc...ricas population has access to grid-based electric...
Breaking Biology News(10 mins):Compound has potential for new class of AIDS drugs 2University of Minnesota to host world's largest conference on evolution 2Undergraduates develop 'dirt-powered' microbial fuel cells to light Africa 2Undergraduates develop 'dirt-powered' microbial fuel cells to light Africa 3Insulet Corporation Announces Pricing of Secondary Public Offering 5721 1Insulet Corporation Announces Pricing of Secondary Public Offering 5721 2Vital Therapies Announces Presentation of ELAD 28R 29 Artificial Liver Data at American Association for the Study of Liver Diseases 2007 Annual Meetin 783 1Vital Therapies Announces Presentation of ELAD 28R 29 Artificial Liver Data at American Association for the Study of Liver Diseases 2007 Annual Meetin 783 2Drug slows prostate tumor growth by keeping vitamin A active 5717 1Drug slows prostate tumor growth by keeping vitamin A active 5717 2Providence Service Corporation Announces 35 25 Revenue Growth with Third Quarter Results 3B Increases Revenue Guidance for 2007 5714 1Providence Service Corporation Announces 35 25 Revenue Growth with Third Quarter Results 3B Increases Revenue Guidance for 2007 5714 2Providence Service Corporation Announces 35 25 Revenue Growth with Third Quarter Results 3B Increases Revenue Guidance for 2007 5714 3Providence Service Corporation Announces 35 25 Revenue Growth with Third Quarter Results 3B Increases Revenue Guidance for 2007 5714 4Providence Service Corporation Announces 35 25 Revenue Growth with Third Quarter Results 3B Increases Revenue Guidance for 2007 5714 5Providence Service Corporation Announces 35 25 Revenue Growth with Third Quarter Results 3B Increases Revenue Guidance for 2007 5714 6Providence Service Corporation Announces 35 25 Revenue Growth with Third Quarter Results 3B Increases Revenue Guidance for 2007 5714 7Providence Service Corporation Announces 35 25 Revenue Growth with Third Quarter Results 3B Increases Revenue Guidance for 2007 5714 8Providence Service Corporation Announces 35 25 Revenue Growth with Third Quarter Results 3B Increases Revenue Guidance for 2007 5714 9Providence Service Corporation Announces 35 25 Revenue Growth with Third Quarter Results 3B Increases Revenue Guidance for 2007 5714 10
...is accelerating and threatening human well-being, ...issue of the journal Science published by AAAS, ...n disappearing from ocean ecosystems and this tren...r Boris Worm. "Now we begin to see some of the con...tinues, all fish and seafood species are projected...
...matic moderate asthma who were treated with anti-t...onoclonal antibody, experienced significantly fewe...placebo. , This research appears in the first issu...iratory and Critical Care Medicine, published by t... M.D., Ph.D., of the National Heart and Lung Insti...
... regarding consciousness, emotion and quality of l...eral Sclerosis (ALS, also known as ,Lou Gerhig,s d...h on brain-computer interaction. ALS is a progress...nt. The study appears in the latest issue of Psych... currently available brain-computer –interfaces (B...
...chemist by training, first ventured into nerve reg...eers would have considered him crazy. , His idea w...signals often conducted by neurotransmitters (chem...and the rest of the body, he could build neurotran... circuit. The neurotransmitters could coax the neu...
Other Biology News:By 2048 all current fish, seafood species projected to collapse 2By 2048 all current fish, seafood species projected to collapse 3Monoclonal antibody reduces exacerbations in asthmatics 2Computer with brain connections changing quality of life of paralyzed 2Dopamine used to prompt nerve tissue to regrow 2
(Date:5/15/2008)...f., May 16 /-,Bayer HealthC..., Inc.,(Nasdaq: ONXX ) today announced more than ... of Clinical Oncology (ASCO) annual meeting demons...ablets in multiple tumor types as,a single agent o...O will expand upon and support the proven efficacy...
(Date:5/15/2008)...erminate Marketing Agreement with Triax Aest...erms, NAPA, Calif., May 15 /PRNewswire-FirstCall/...e Sciences company engaged in the development,of t...ng, today announced,financial results for the quar...iple to terminate its marketing agreement with Tri...
(Date:5/15/2008)...wire-FirstCall/ -- Indevus,Pharmaceuticals, Inc. (...ill,present at the Rodman & Renshaw 5th Annual Glo...p.m. local time (10:55 a.m. EDT) and at the 2008 U...nference on Thursday, May,29, 2008 at 10:00 a.m. l...be web cast live and may be accessed by visiting t...
(Date:5/15/2008)...re-FirstCall/ -- Hologic, Inc. (Nasdaq:,HOLX) toda...er, will be,presenting at the Citigroup Investment...May 21 - 22, 2008, at the Hilton Hotel in New York...o a live audio webcast of,Hologic,s investor prese...astern Time on the investor section of the Company...
Breaking Biology Technology:Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 2Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 3Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 4Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 5Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 6Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting 7Senetek PLC Reports First Quarter 2008 Financial Results 2Senetek PLC Reports First Quarter 2008 Financial Results 3Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences 2Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences 3
...thal fungal infection is caused by a mold called ...ukemia and HIV/AIDS patients at serious risk. OpG...s created a whole genome map of this fungal pathog...esearchers to find new therapeutics to treat this...s their technology will lead to major breakthrough...
...n provider of medical imaging, point-of-care syste...y, announced today that it has received top recogn...lthcare industry authority, KLAS Enterprises for t...ntricity(R) Pharmacy Information System, was recog...ises , a research and consulting firm specializing...
... final week, I promised I,d share a little bit abo... at DEMO, but in the week ahead. , ,What strikes m...ls a lot like the enterprise market some 20 years ...S departments in the early 80s) is acutely focused...he infrastructure of corporate computing. , ,Havi...
...f operation, the University of Wisconsin-Madison ...iness and community-related success. The office wa... who charged it with serving the needs of the busi...the resources of the university more accessible to...clude interfacing with over 300 companies in Wisco...
Other Biology Technology:OpGen Creates Map of Worlds Most Lethal Fungus 2The Enterprise and the Individual 2The Enterprise and the Individual 3
... Metabolic Profiler is an integrated platform for ...es. It features an HPLC-microTOF ESI-TOF system, a...software for data acquisition, evaluation and stat... of the metabolic profile of a living organism to ...
...f movement counts, similar to an infrared beam bre...ts at once, in two frames of reference, recording ...inate with other signals such as EEG. Can use ani...na rotations or reinforcemnts to the animal. Test...
... cultivation of microorganisms and human or animal...utical products maximum performance and economy fo...ntation 10 L 1,500 L. ,*Sterile design, free of d...*High-quality components ,*cGMP documentation pac...
tracking dye in electrophoresis; free acid, C 19 H 10 BrO 5 S; MW: 669.96
Biology Products: